/Investor DB

Arcus Ventures — Full Portfolio

3 tracked investments · listed companies and verified rows first

Exosome DiagnosticsinSeries B · Mar 2014 · $27M

BiotechHealthtechCambridge, US

James McCullough(Executive Officer, Director)William Kelly(Chief Financial Officer and Secretary of Issuer)Thomas McLain(Chief Executive Officer and Director of Issuer)Sara Barrington(Executive Officer)

BoardJoseph Boystak(Director)inGeert-Jan Mulder(Director)in

Co-investorsForbionNGN Capital

T2 Biosystemst2biosystems.cominSep 2016 · $15M

HealthtechLexington, US

Michael Cima, Ph.D.(Director)Rahul Dhanda(Senior Vice President, Corporate Development)inJohn McDonough(Chief Executive Officer)inTom Lowery, Ph.D.(Chief Scientific Officer)Michael Gibbs, Esq.(Vice President and General Counsel)Joanne Spadoro, Ph.D.(Chief Operating Officer)in

Co-investorsAisling CapitalAPERTURE Venture PartnersFlagship VenturesFlybridge Capital PartnersJohnson & Johnson Innovation – JJDCPolaris Partners+1 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

MI Bioresearch

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.